Novacyt (XPAR:ALNOV) Long-Term Debt : €0.00 Mil (As of Jun. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Novacyt Long-Term Debt?

Novacyt's Long-Term Debt for the quarter that ended in Jun. 2023 was €0.00 Mil.

Novacyt Long-Term Debt Historical Data

The historical data trend for Novacyt's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novacyt Long-Term Debt Chart

Novacyt Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Long-Term Debt

Get a 7-Day Free Trial

2.33

7.03

Novacyt Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Long-Term Debt	Get a 7-Day Free Trial															-	-	-	-	-

Novacyt (XPAR:ALNOV) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Novacyt Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Novacyt's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Novacyt (XPAR:ALNOV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Novacyt SA (XPAR:ALNOV) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

NVYTF:USA NCYT:UK NYZ:Germany

Address

13, Avenue Morane Saulnier, Velizy-Villacoublay, FRA, 78140

Website

https://www.novacyt.com

Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments. Primerdesign is the designer, manufacturer, and marketer of molecular 'real-time' qPCR testing devices and reagents in the areas of infectious diseases based in Southampton, UK: IT-IS International segment develops PCR devices for the life sciences and food testing industry and Corporate segment.

Novacyt (XPAR:ALNOV) Headlines

No Headlines